Cover Image

Instant rule-out of suspected non-ST-segment elevation myocardial infarction using high-sensitivity cardiac troponin T with Copeptin versus a single low high-sensitivity cardiac troponin T: findings from a large pooled individual data analysis on 10,329 patients

Evidence is sparse and inconsistent on the role of a dual marker strategy (DMS) combining Copeptin with cardiac troponin T (cTnT) for instant rule-out of a non-ST-segment myocardial infarction (NSTEMI) when high sensitivity cardiac troponin T (hs-cTnT) is used.

Saved in:
Bibliographic Details
Main Authors: Giannitsis, Evangelos (Author) , Huber, K. (Author) , Hamm, Christian (Author) , Möckel, M. (Author)
Format: Article (Journal)
Language:English
Published: 2021
In: Clinical research in cardiology
Year: 2021, Volume: 110, Issue: 2, Pages: 194-199
ISSN:1861-0692
DOI:10.1007/s00392-020-01712-y
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00392-020-01712-y
Get full text
Author Notes:Evangelos Giannitsis, K. Huber, C.W. Hamm, M. Möckel
Description
Summary:Evidence is sparse and inconsistent on the role of a dual marker strategy (DMS) combining Copeptin with cardiac troponin T (cTnT) for instant rule-out of a non-ST-segment myocardial infarction (NSTEMI) when high sensitivity cardiac troponin T (hs-cTnT) is used.
Item Description:Published online: 15 July 2020
Gesehen am 07.10.2021
Physical Description:Online Resource
ISSN:1861-0692
DOI:10.1007/s00392-020-01712-y

Similar Items